
                     -Ascorbyl-2-phosphate attenuates NF-κB signaling in SZ95 sebocytes without affecting IL-6 and IL-8 secretion by unknown
ORIGINAL PAPER
L-Ascorbyl-2-phosphate attenuates NF-jB signaling in SZ95
sebocytes without affecting IL-6 and IL-8 secretion
Hiroshi Ikeno1 • Mara Apel2 • Christos Zouboulis3 • Thomas A. Luger2 •
Markus Bo¨hm2
Received: 19 September 2014 / Revised: 31 March 2015 / Accepted: 11 April 2015 / Published online: 18 April 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Acne is the most common inflammatory skin
disease. Interleukin-1 (IL-1) is at the beginning of the cy-
tokine signaling cascade and may be involved in the
pathogenesis of this disorder. It activates redox-sensitive
transcription factors, which induce IL-6 and IL-8 expres-
sion. Interestingly, L-ascorbyl-2-phosphate (APS) was
shown to have beneficial effects in patients with acne
vulgaris. The mechanism of action of this agent remains
unknown. Here, we investigated if APS attenuates IL-1b-
or TNF-a-mediated IL-6 and IL-8 expression in SZ95 se-
bocytes, whereas TNF-a was used as control. We also
explored NF-jB activation which is known to orchestrate
IL-1b- and TNF-a-mediated cytokine expression in many
cell types. Both IL-1b and TNF-a increased IL-6 and IL-8
mRNA expression in SZ95 sebocytes. However, only IL-
1b induced IL-6 and IL-8 secretion. IL-1b but not TNF-a
activated NF-jB canonical signaling as demonstrated by
Ij-Ba phosphorylation and degradation as well as by nu-
clear accumulation of NF-jB/p65. Concomitant treatment
of SZ95 sebocytes with APS attenuated the effect of IL-1b
and TNF-a on IL-6 and IL-8 gene expression as well as on
IL-1b-mediated NF-jB signaling. In contrast, APS failed
to reduce IL-1b-mediated IL-6 and IL-8 secretion, pre-
sumably by maintained IL-1b-mediated p38 activation,
which is known to control IL-8 secretion. Our findings shed
light into the impact of IL-1b on the inflammatory cytokine
response and its molecular mechanisms in human sebo-
cytes. Our data further suggest that the beneficial effect of
APS in acne patients involves attenuation of NF-jB sig-
naling but not reduction of IL-6 or IL-8 secretion.
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Introduction
Acne is considered the most common inflammatory skin
disorder. It is estimated that about 93 % of adolescents
suffer from acne vulgaris [9], the most common subtype of
acne. Albeit our current therapeutic armamentarium
against acne vulgaris encompasses a panel of usually very
effective topical and/or systemic treatments other subtypes
of acne such as acne conglobata, smokers’ acne or acne
tarda can still be a therapeutic challenge.
Elucidating the key events that lead to an uncontrolled
inflammatory response of the pilosebaceous unit will be
crucial to optimize our current therapeutic options and to
tailor new treatments against acne. Among the various
proinflammatory mediators interleukin-1 (IL-1) is the most
upstream player within the cytokine cascade. On the other
hand, tumor necrosis factor-a (TNF-a) seems to play a
minor role in acne inflammation. Nevertheless both cy-
tokines are robust inducers of IL-6 and IL-8 gene expres-
sion [5, 25] and propagate an initial inflammatory response
of the pilosebaceous unit in acne [21]. IL-1a-like bioac-
tivity is present in the majority of open comedones [16].
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Using a skin organ culture model it was further shown that
IL-1a can induce follicular hyperkeratinisation [12]. Pro-
pionibacterium acnes and oxidized lipids, both implicated
in the pathogenesis of acne vulgaris, are also capable of
directly inducing proinflammatory cytokine production in
human epidermal keratinocytes and HaCaT cells [11, 27,
31]. Recently, Kistowska et al. [18] further demonstrated
that IL-1b and the active processed forms of this cytokine
are abundant in inflammatory acne lesions. Interestingly,
P. acnes was found to activate the inflammasome in
monocytes/macrophages. A role of IL-1 in mediating in-
flammation of the pilosebaceous unit is finally highlighted
by the successful treatment of patients with PAPA syn-
drome with IL-1 antagonists [4]. Of note, IL-1 is primarily
secreted by monocytes/macrophages [7] and the reported
impact of this cytokine on keratinocyte proliferation is not
specific for acroinfundibular keratinocytes. There is cur-
rently no evidence for an increased sensitivity of acroin-
fundibular keratinocytes to IL-1 or increased expression of
this cytokine compared to interfollicular keratinocytes [17].
Thus, induction of IL-1 in acne may be regarded as a rather
non-specific response of the pilosebaceous unit which is
superimposed on increased sebaceous lipogenesis linked to
increased insulin-like growth factor and androgen signaling
of puberty [23].
L-Ascorbyl-2-phosphate (APS) is a stable antioxidant
derived from vitamin C. In previous open-label studies 5 %
sodium APS lotion appeared to have anti-inflammatory
effects in patients with acne vulgaris. These beneficial ef-
fects of topical APS in acne were recently confirmed in a
randomized double-blind controlled trial [32]. The precise
mechanism by which topical APS elicits its anti-inflam-
matory effects in patients with acne vulgaris remains un-
known. However, APS may exert suppressive effects on
expression of distinct proinflammatory cytokines, which
are known to be induced in a redox-sensitive manner, i.e.,
by activation of canonical nuclear factor-jB (NF-jB) sig-
naling [10]. Notably, magnesium APS has previously been
shown to exert protective and anti-inflammatory effects on
UVB-treated mouse skin [19, 26], Moreover, various APS
salts (e.g., sodium, calcium, magnesium) at doses ranging
from 0.01 to 3 % are used in cosmetics in which they
function as antioxidants and possibly also as weak anti-
inflammatory cosmeceuticals [8]. However, despite of the
mechanistic link between oxidative stress and inflamma-
tion in general the commonly used antiacne agent benzoyl
peroxide is a strong oxidant.
Given the potential role of IL-1 in the pathogenesis of
acne we investigated the molecular mechanism of proin-
flammatory cytokine induction and signaling in human
sebocytes. To this end we used the immortalized human
sebaceous gland cell line SZ95 derived from facial human
sebaceous glands [35]. In addition, we tested the hypothesis
as to whether APS can alter the impact of IL-1 and/or TNF-
a (used as a control) on canonical NF-jB signaling and
proinflammatory cytokine induction in these cells.
Materials and methods
Cell culture and reagents
SZ95 sebocytes were routinely maintained in Sebomed
basal medium supplemented with 5 ng/ml human epider-
mal growth factor, 10 % fetal calf serum (FCS) (both from
Biochrom, Berlin, Germany), 1 % L-glutamin, 1 % peni-
cillin/streptomycin and 1 mM CaCl2 in a humidified at-
mosphere containing 5 % CO2 at 37 C [35]. APS was
purchased from Fluka (Taufkirchen, Germany), IL-1b from
Biomol (Hamburg, Germany) and TNF-a from Immuno-
tools (Friesoythe, Germany). Prior to stimulation with cy-
tokines SZ95 sebocytes were deprived for 24 h in 0.1 %
FCS (for all studies involving IL-1b) or 0 % FCS (for all
studies with TNF-a).
Cell viability assays
SZ95 sebocytes were seeded into 96-well tissue culture
plates at a density of 10,000 cells/well. The following day
cells were treated with APS at indicated doses in presence
of 0.1 % FCS. Cell viability was measured by the XTT kit
after 48 h (Roche, Mannheim, Germany). Quintuplicates
were used for all treatments. Experiments were performed
independently three times.
Real-time RT-PCR
Cells were seeded into 3.5 cm Ø tissue culture dishes at a
density of 2 9 105 cells per dish. Following deprivation
from FCS and stimulation as indicated established proto-
cols were used for total RNA preparation, cDNA synthesis
and real-time RT-PCR [22]. In short, total RNA was pre-
pared by the RNeasy kit (Qiagen, Hilden, Germany)
followed by DNAse I treatment cDNA synthesis using
oligo-dT primers and RevertAid M-MuLV reverse tran-
scriptase (Fermentas Life Sciences, Hanover, MD, USA).
Real-time RT-PCR was performed with Taq polymerase
(Promega, Mannheim, Germany) in a total volume of 20 ll
with SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA) and a 200 nM concentration of intron-
spanning primers. The primer sequences for IL-6 and IL-8
were identical as described before [22]. Primers for cy-
clooxygenase 2 (COX2) were sense 50-TTGCTGGAACAT
GGAATTACCC-30 and anti-sense 50-GCATAAAGCGTT
TGCG-GTACTC-30. Reactions were carried out in dupli-
cates in an ABI-prism 7000 sequence detector supplied
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with SDS 2.2 software (Applied Biosystems) using the
following conditions: an initial activation step (2 min at
50 C), a single denaturation step (15 min at 95 C), fol-
lowed by 40 cycles of 15 s at 95 C and 60 s at 60 C, and
a final cycle of 15 s at 95 C, 30 s at 60 C and 15 s at
95 C. Levels of gene expression in each sample were
quantified applying the 2-DDCT method with glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) as an en-
dogenous control. GAPDH primers were identical with
those reported before [20].
IL-6 and IL-8 protein analysis
Commercially available ELISAs from Ray Bio (Norcross,
GA) were used to determine the amounts of IL-6 and IL-8
proteins generated by SZ95 sebocytes. Secreted levels of
IL-6 and IL-8 were measured in culture supernatants of
cells seeded into 3.5 cm Ø tissue culture dishes at a density
of 200,000 cells per dish. All measurements were per-
formed in duplicates according the manufacturer’s proto-
col. Experiments were performed independently at least
three times.
Detection of prostaglandin E2
A commercially available ELISA from Cayman (Ann Ar-
bor, MI) was used to measure prostaglandin E2 (PGE2) in
cell culture supernatants of SZ95 sebocytes. Cells were
stimulated as outlined above followed by duplicate mea-
surements according to the manufacturer’s protocol.
Western immunoblotting
Serum-deprived SZ95 sebocytes were stimulated with IL-
1b or TNF-a alone or in combination with APS as indi-
cated. Cells were then either directly harvested in boiling
Laemmli buffer or processed for subcellular fractionation
as described before [22]. Protein concentrations in cyto-
plasmic and nuclear extracts were determined by the DC
Protein assay kit (BioRad, Hercules, CA). Identical
amounts of protein were resolved by 10 % SDS-PAGE,
electrotransferred to PVDF membranes, blocked with 2 %
blocking reagent (Roche, Mannheim Germany) and incu-
bated with primary antibodies in 1 % blocking reagent
overnight at 4 C. Primary antibodies were anti-IjBa
(IMGENEX, San Diego, CA), NF-jB/p65 (Biomol), anti-
phospho-IjBa, anti-COX2, anti-phospho-p38 mitogen-ac-
tivated protein kinase (MAPK) and anti-phospho-p42/p44
MAPK1/2 (all from Cell Signaling, Frankfurt am Main,
Germany). Equal loading of protein lysates for the detec-
tion of phosphorylated p38 MAPK and phospho-p42/p44
MAPK1/2 was confirmed by stripping and reprobing the
membranes with anti-p38 MAPK and anti-p42/p44
MAPK1/2 antibodies (both from Cell Signaling). In some
experiments, phorbol 12-myristate 13-acetate (PMA,
50 ng/ml) was used as positive control. After washing,
membranes were incubated with secondary horseradish
peroxidase conjugated antibodies (Amersham-Pharmacia)
in 1 % blocking reagent for 1 h at room temperature.
Bound antibodies were detected using the ECL Plus
chemiluminescent reagent (Amersharm-Pharmacia). Iden-
tical nuclear protein loading was confirmed by stripping the
blot and reprobing it with anti-a-tubulin antibodies (Cal-
biochem, Schwalbach, Germany) or with an antibody
against the TATA-binding protein (TBP; Abcam, Milton,
UK).
Immunofluorescence analysis
SZ95 sebocytes were seeded into 8-well chamber slides at
a density of 10,000 cells per well. After deprivation from
FCS as outlined above and stimulation with IL-1b or TNF-
a alone and in combination with APS stand cells were fixed
with methanol for 30 min at -20 oC. Non-specific binding
was then blocked with 5 % donkey serum for 1 h at room
temperature followed by incubation for 1 h with a rabbit
polyclonal antibody against NF-jB p65 (Santa Cruz
Biotechnology Inc., San Diego, CA). Bound antibodies
were detected with a donkey anti-rabbit antibody coupled
to Texas Red (1:1500; Dianova, Hamburg, Germany).
Cells were imaged and examined with a fluorescence mi-
croscope (Carl Zeiss, Oberkochen, Germany). Red
fluorescence was excited using the TX3 filter
(530–585 nm). Slides were finally imaged by fluorescence
microscopy (Carl Zeiss, Jena, Germany).
Densitometry
Western blot images were processed for densitometric
analysis using the freely available software Image J (http://
rsbweb.nih.gov/ij). Mean intensities were corrected for
background followed by normalization with the corre-
sponding housekeeping gene products a-tubulin, nuclear
TBP, or non-phosphorylated proteins (p38, ERK1/2) in
case of phosphorylated kinases. For multiple experiments
and statistical analysis mean intensities of control samples
(non-treated, cytokine- or PMA-treated cells) were set as 1
and changes of intensity were calculated as fold increase or
decrease from control.
Data analysis
All experiments were performed at least three times. Data
were calculated as mean ± SD followed by statistical
analysis using the Student’s t test for unpaired experiments.
A p value of\0.05 was considered statistically significant.
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Results
Effects of APS on IL-6 and IL-8 mRNA expression
in SZ95 sebocytes
We first determined the effect of APS at various doses on
the cell viability of sebocytes in vitro using XTT test. In-
cubation of SZ95 sebocytes with APS for 48 h revealed
that doses of 1–1000 lg/ml were non-cytotoxic as shown
in online resource 1 (Supplemental Figure 1). Next, the
effect of APS on IL-6 and IL-8 mRNA expression was
investigated by real-time RT-PCR after stimulation of
SZ95 sebocytes with IL-1b or TNF-a. Previously, we had
established that IL-1b has a time- and dose-dependent ef-
fect on the steady-state levels of both IL-6 and IL-8
mRNAs in SZ95 sebocytes [22]. Therefore, we used IL-1b
at 0.1 ng/ml, which reproducibly and robustly increased
the mRNA amounts of both IL-6 and IL-8 mRNA in SZ95
sebocytes, i.e., *six- to tenfold over control (p\ 0.001)
(Fig. 1a, b). With regard to TNF-a only very high doses of
this cytokine were capable of reproducibly increasing the
mRNA levels of both IL-6 and IL-8 (online resource 1,
Supplemental Figure 2a, b). Thus, for all subsequent
studies TNF-a at 10 ng/ml was used. Interestingly, APS at
all tested doses (1–100 lg/ml) reduced IL-1b-mediated
expression of both IL-6 and IL-8 mRNA. This effect of
APS appeared to be dose-dependent for IL-8 mRNA ex-
pression with an IC50 of *100 lg/ml (Fig. 1a, b). Like-
wise, APS suppressed TNF-a-mediated mRNA expression
of both IL-6 and IL-8 at the majority of tested doses albeit
no clear-cut dose-kinetic effect could be detected (Fig. 1c,
d). APS tested at various doses per se did not change the































































































































Fig. 1 APS suppressed IL-1b- and TNF-a-mediated mRNA expres-
sion of IL-6 (a, c) and IL-8 (b, d) in SZ95 sebocytes. Cells were
treated with IL-1b (0.1 ng/ml), TNF-a (10 ng/ml) alone or in
combination with APS at indicated doses for 6–8 h followed by
real-time RT-PCR analysis. ***p\ 0.001, **p\ 0.01, *p\ 0.05 vs.
IL-1b or TNF-a; n = 3
cFig. 2 Impact of IL-1b, TNF-a and APS on NF-jB activation in
SZ95 sebocytes. Time kinetics of IL-1b- (a) and TNF-a- (b) mediated
IjBa phosphorylation and protein degradation. Cells were treated
with IL-1b (0.1 ng/ml) or TNF-a (10 ng/ml) as indicated followed by
Western immunoblotting of total cell lysates with antibodies against
phosphorylated and total IjBa. To ensure equal protein loading
membranes were reprobed with an anti-tubulin-a antibody. Expres-
sion of phosphorylated and total IjBa was quantified by den-
sitometry. Time kinetic analysis of nuclear accumulation of NF-jB/
p65 after stimulation with IL-1b or TNF-a (c). Nuclear extracts were
processed by Western immunoblotting using antibodies against NF-
jB/p65. Nuclear protein loading was controlled by reprobing with an
anti-TBP antibody. Expression of phosphorylated and total IjBa was
quantified by densitometry. APS reduces nuclear translocation of NF-
jB/p65 following stimulation with IL-1b (d). Nuclear translocation of
NF-jB/p65 was assessed by immunofluorescence 30 min after
stimulation. Panels depict representative images of at least three
independent experiments with identical results. APS attenuates NF-
jB activation as shown by reduced phosphorylation of IjBa (e).
Phosphorylation of IjBa was determined by Western immunoblotting
as outlined above. Expression of NF-jB/p65 was quantified by
densitometry
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mRNA expression levels of IL-6 and IL-8 (data not
shown).
Impact of IL-1b, TNF-a and APS on NF-jB
signaling in SZ95 sebocytes
Since IL-6 and IL-8 expression is well known to be
regulated by canonical NF-jB signaling we next wondered
whether APS affects the activation of this key regulator of
inflammatory cytokine responses. Upon stimulation with
IL-1b or TNF-a NF-jB is activated by phosphorylation of
IjBa followed by proteasomal degradation of this protein.
Homo- or heterodimers of NF-jB/p65 or NF-jB/p50
translocate then to the nucleus and bind to NF-jB con-
sensus elements, for example., in the promoters of IL-6 and
IL-8. However, comparative studies on the activation of
NF-jB by IL-1b and TNF-a have not been performed to
the best of your knowledge in SZ95 sebocytes. Stimulation
of these cells with IL-1b led to a time-dependent phos-
phorylation of IjBa as shown by Western immunoblotting
(Fig. 2a, lower panel). This IL-1b-mediated phosphoryla-
tion was statistically significant 15 min after stimulation
(mean increase: 5.94 ± 1.51-fold, n = 3, p\ 0.01). In
contrast, no significant phosphorylation of IjBa was de-
tected upon stimulation of SZ95 sebocytes with TNF-a
(Fig. 2b, lower panel). In accordance with these findings
the protein amounts of IjBa were time dependently re-
duced (statistically significant at 30 min; mean decrease:
0.18 ± 0.03-fold, p\ 0.0001, n = 3) after IL-1b but not
after TNF-a treatment (Fig. 2a, b, upper panel). Time ki-
netic analyses using nuclear extracts further revealed that
the amounts of NF-jB/p65 accumulated in the nucleus
over time in response to IL-1b (statistically significant at
30 min; mean increase: 2.36 ± 0.33-fold, n = 3, p\ 0.01)
but not after TNF-a (Fig. 1c). Next, the impact of APS was
assessed in SZ95 sebocytes using two NF-jB activation
read-outs after stimulation with IL-1b. Nuclear transloca-
tion of NF-jB/p65 was reduced by APS as shown by im-
munofluorescence analysis (Fig. 2d). As shown by Western
immunoblotting APS (10 lg/ml) also markedly reduced
the extent of IjBa phosphorylation in cells stimulated with
IL-1b (mean decrease: 0.37 ± 0.02-fold, p\ 0.05, n = 4)
(Fig. 2e). As expected, APS did neither alter the expression
or phosphorylation of IjBa nor the immunolocalization of
NF-jB/p65 in SZ95 sebocytes treated with TNF-a (data
not shown).
APS does not alter IL-1b and TNF-a-mediated
secretion of both IL-6 and IL-8 by SZ95 sebocytes
The findings show that APS reduces both IL-1b- and TNF-
a-mediated mRNA expression of IL-6 and IL-8 and is also
capable of attenuating IL-1b-mediated NF-jB activation
suggested that this antioxidant may also suppress the se-
cretion of IL-6 and IL-8 by SZ95 sebocytes. Thus, the
levels of IL-6 and IL-8 were determined by ELISA after
stimulation of SZ95 sebocytes with IL-1b and TNF-a alone
and in presence of different concentrations of APS.
Stimulation with IL-1b (0.1 ng/ml) for 24 h resulted in a
significant increase in the secreted amounts of both IL-6
and IL-8 (p\ 0.001) (Fig. 3a, b). However, in contrast to
the corresponding mRNA levels (Fig. 1a, b) APS at doses
ranging from 1 to 100 lg/ml failed to alter IL-1b-mediated
secretion of both cytokines in SZ95 sebocytes compared
with IL-1b alone (Fig. 3a, b). Stimulation of cells for
shorter time periods, i.e., for 3 and 12 h, likewise did not
disclose a modulatory effect of APS on IL-1b-mediated
secretion of both cytokines. As expected, APS per se did
not affect secretion of IL-6 and IL-8 as determined by
stimulation of cells with one representative APS dose
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sebocytes exposed to TNF-a alone or in combination with
APS were further tested we could not detect any significant
changes in the amount of both IL-6 and IL-8 compared to
non-treated controls (data not shown).
APS does not alter IL-1b-mediated activation of p38
MAPK in SZ95 sebocytes
Puzzled by the observation that APS attenuates IL-1b-
mediated NF-jB activation (Fig. 2c–e) and NF-jB-de-
pendent gene expression but does neither suppresses IL-6
nor IL-8 secretion we wondered as to whether this an-
tioxidant may alter the activation of MAPKs in SZ95 se-
bocytes. Detailed molecular studies from others revealed
that distinct members of the MAPK family, especially p38
MAPK, are crucially involved in the regulation of IL-8
secretion in the context of NF-jB-mediated IL-8 gene
expression [14]. Thus, we checked the activated state of
p38 MAPK in total cell lysates of SZ95 sebocytes by
Western immunoblotting using phosphospecific antibodies.
Treatment with IL-1b induced significant phosphorylation
of p38 MAPK in SZ95 sebocytes (mean increase:
1.64 ± 0.31-fold, p\ 0.05, n = 3). However, concomitant
incubation with APS did not alter the extent of p38 MAPK
phosphorylation (Fig. 4a). Interestingly, APS per se de-
creased p38 MAPK phosphorylation (mean decrease:
0.30 ± 0.28-fold, p\ 0.05, n = 3). The lack of an effect
of APS on IL-1b-mediated p38 MAPK phosphorylation
was further observed when cells were treated with the ar-
tificial protein kinase C activator PMA (online resource 1,
Supplemental Figure 3a). Here, PMA increased p38
MAPK phosphorylation without further modulation by
APS. In contrast to these findings we could not detect any
changes in the phosphorylated state of p42/p44 MAPK1/2/
ERK1/2 (extracellular signal-regulated kinase 1/2) in SZ95
sebocytes by IL-1b compared to non-stimulated cells
(Fig. 4b). Likewise PMA did not alter constitutive p42/p44
ERK1/2 phosphorylation in SZ95 sebocytes (online re-
source 1, Supplemental Figure 3b). Given the regulatory
role of p38 MAPK on IL-8 secretion we also wondered
whether phosphorylation of p38 MAPK would be
modulated by TNF-a or APS in SZ95 sebocytes. Treatment
with either substances (or both) interestingly reduced the
phosphorylated state of this kinase (for TNF-a mean de-
crease: 0.47 ± 0.18-fold, p\ 0.05, n = 4) (Fig. 4c). In
contrast, neither TNF-a nor TNF-a plus APS had sig-
nificant effects on ERK1/2 phosphorylation in SZ95 se-
bocytes in multiple experiments (Fig. 4d).
Impact of IL-1b, TNF-a and APS on COX2
expression and PGE2 secretion in SZ95 sebocytes
We finally investigated the effects of IL-1b, TNF-a and
APS on the expression of COX2 and PGE2 in SZ95 se-
bocytes. PGE2 has been implicated in the pathogenesis of
acne and has also been suggested to be a viable target for
the treatment of this disease [28, 33, 34]. Previous studies
had revealed the presence of the full enzymatic machinery
for the biosynthesis of leukotriene B4 and PGE2 in seba-
ceous glands of acne patients and SZ95 sebocytes, re-
spectively [2]. Albeit it was shown that arachidonic acid
stimulated the biosynthesis of PGE2 in SZ95 sebocytes, the
impact of IL-1b and TNF-a on COX2 expression and PGE2
secretion is unknown. As demonstrated by real-time RT-
PCR both IL-1b and TNF-a had upregulating effects on the
mRNA level of COX2 (p\ 0.05, n = 3 for IL-1b;
p\ 0.05, n = 4 for TNF-a) (Fig. 5a, b). Interestingly, APS
at all tested doses (1–100 lg/ml) suppressed the effect of
TNF-a but not of IL-1b on COX2 mRNA expression
(Fig. 5a, b). However, the modulating effects of TNF-a,
IL-1b and also of APS—in case of TNF-a-mediated COX2
mRNA expression—were not associated with altered
COX2 protein levels in SZ95 sebocytes (Fig. 5c). This lack
of an effect of IL-1b and TNF-a on COX2 was confirmed
by measuring the amounts of PGE2 in the supernatants of
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Fig. 3 Effect of APS on IL-1b- and TNF-a-mediated IL-6 (a) and IL-
8 (b) secretion by SZ95 sebocytes. Cells were stimulated with IL-1b
(0.1 ng/ml), TNF-a (10 ng/ml) alone or in combination with APS at
indicated doses for 24 h followed by ELISA, n = 3































































































































































BFig. 4 Effects of IL-1b, TNF-a
and APS on p38 MAPK (a,
c) and p42/p44 ERK1/2 (b,
d) phosphorylation in SZ95
sebocytes. Cells were stimulated
with IL-1b (0.1 ng/ml) and
TNF-a (10 ng/ml) alone or in
combination with APS (1 mg/
ml) for 30 min followed by
Western immunoblotting with
phosphospecific antibodies
against p38 MAPK and p42/p44
ERK1/2. To ensure equal
protein loading membranes
were reprobed with antibodies
against total p38 MAPK and




images of 3 independent
experiments with similar results
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SZ95 sebocyte cultures. Basal secretion of PGE2 within
24 h was 73.19 ± 3.6 pg/ml per 100,000 cells. Neither IL-
1b, TNF-a nor APS had any impact on the levels of PGE2.
Further, different time points, i.e., stimulation with the
above agents for 1, 3 and 16 h, did not have any effect on
the secretion of this short-term mediator (data not shown).
Discussion
In this study we have examined the impact of two key
proinflammatory cytokines, IL-1b, TNF-a, but also of the
antioxidant APS on IL-6 and IL-8 expression and NF-jB
signaling in the human sebaceous gland cell line SZ95.
While IL-1 has been shown to be involved in inflammatory
processes in human sebocytes in vivo and in vitro, TNF-a
is probably not a mediator of inflammation in these cells.
Our hypothesis to test APS in this context was first based
on the clinical observation that APS has beneficial effects
in patients with acne vulgaris [32]. Second, APS is an
antioxidative vitamin C derivative. Previous studies re-
vealed that vitamin C is capable of reducing NF-jB-de-
pendent induction of IL-8 gene expression by TNF-a in the
human histiocytoma lymphoma cell line U937 [30].
Moreover, vitamin C inhibited activation of NF-jB and
NF-jB-dependent gene IL-8 expression by TNF-a in the
endothelial cell line ECV304 and in primary human um-
bilical vascular endothelial cells [3]. Bowie and O´Neill [3]
disclosed that vitamin C blocked IL-1a and TNF-a-medi-
ated degradation and phosphorylation of IjBa due to in-
hibition of IjB kinase activation. However, in both of these
studies it was not described if vitamin C also inhibited IL-8
protein expression or secretion. Our findings on the in-
hibitory effect of APS on IL-1b in SZ95 sebocytes are in
accordance with the previously described effect of vitamin
C in U937 and endothelial cells. Accordingly, attenuation
of NF-jB signaling in SZ95 sebocytes was demonstrated








































































































bFig. 5 Impact of IL-1b, TNF-a and APS on COX2 mRNA (a, b) and
protein expression (c) in SZ95 sebocytes. Expression of COX2
transcripts was determined by real-time RT-PCR following stimula-
tion of cells with either IL-1b or TNF-a (10 ng/ml) alone or in
combination with APS for 8 h. *p\ 0.05 vs. control for IL-1b,
n = 3; *p\ 0.05 vs. TNF-a, n = 4. Expression of COX2 protein was
assessed by Western immunoblotting following stimulation of cells
with IL-1b or TNF-a as indicated. Expression of COX2 protein was
quantified by densitometry. Panels are representative images of at
least three independent experiments with identical results
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accumulation of NF-jB/p65 following stimulation with IL-
1b. Interestingly, TNF-a, which also induces IL-8 gene
expression, did not appear to affect NF-jB activation in
SZ95 sebocytes as evidenced by the lack of IjBa degra-
dation, phosphorylation and no detectable nuclear accu-
mulation of p65. Thus, NF-jB activation in SZ95
sebocytes seems to be a specific IL-1-mediated event,
indicating a major role of IL-1 in sebocyte inflammatory
processes, as previously shown. Molecular studies revealed
that IL-8 gene expression is extremely complex and coor-
dinated by at least three events: (a) derepression of the gene
promoter; (b) transcriptional activation of the gene by NF-
jB and JUN N-terminal protein kinase pathways; and
(c) stabilization of the mRNA by the p38 MAPK pathway
[13]. For IL-6 gene expression activation of the transcrip-
tion nuclear factor-IL-6 (NF-IL6) is also critical [1]. IL-8
protein expression and secretion was found to depend on
distinct MAPK kinase kinases which can activate NF-jB,
i.e., stress-activated protein kinase/jun N-terminal kinase
and p38 MAP kinases [14]. Indeed, our study is limited as
we have not examined the activation of stress-activated
protein kinase/jun N-terminal kinase by IL-1, TNF-a or
APS. With regard to p38 activation others could detect
phosphorylation of this kinase after TNF-a treatment of
SZ95 sebocytes within 5–10 min followed by a rapid de-
cline to basal levels [6]. This is in contrast to our findings
as we noticed even reduced p38 phosphorylation after
TNF-a and/or APS after 30 min of treatment. While the
reduction of p38 phosphorylation by APS may be related to
the antioxidative effects of this vitamin C derivative the
reason for the reduction of p38 after TNF-a is unclear but
may be due to compensatory dephosphorylation after early
transient phosphorylation that we may have missed by
studying only the 30-min time point. Interestingly, other
noticed even increased p38 phosphorylation after treatment
of ECV304 cells with vitamin C [3] which may be related
to higher doses of this molecule compared to our studies
and cell type-specific differences. In accordance with Choi
et al. [6], however, SZ95 sebocytes displayed constitutive
phosphorylation of both p38 and EKR1/2 even after FCS
starvation. Notably, the latter authors likewise did not find
any modulation of ERK1/2 phosphorylation by TNF-a
which is supported by our studies. Whether the lack of a
IL-6 or IL-8 secretion after TNF-a treatment of SZ95 is
related to the extent or duration of p38 phosphorylation
needs to be addressed in future studies. Our observation,
APS did not affect IL-1b-mediated phosphorylation of p38
MAP kinase, may explain why this agent—despite of its
effect on NF-jB gene expression—failed to reduce IL-1b-
mediated secretion of IL-6 and IL-8.
The finding shows that APS neither reduces IL-6 and IL-
8 protein expression nor affects PGE2 secretion in SZ95
sebocytes suggests another mechanism of action of this
agent in patients with acne vulgaris. Indeed, the SZ95 se-
baceous gland cell line has certain limitations as being an
in vitro model for acne. Moreover, the administered
amounts of APS in patients with acne vulgaris are
markedly higher (5 %) than the doses used in our in vitro
studies. Interestingly, it was reported that the quantities of
lipid peroxides caused by oxidation of sebum, NF-jB/p65
protein and IL-1a are significantly higher in comedones
than those in stratum corneum [29]. Moreover, the an-
tioxidant glutathione was recently found to be lower in the
stratum corneum of patients with acne than in healthy
subjects [17]. In light of these observations and the
modulating effect of APS on NF-jB activation other target
genes than IL-6 or IL-8 may be affected by APS at the
protein level in vivo in acne patients. Thus, it will be very
informative to measure lipid peroxides, glutathione, and
NF-jB/p65 protein in the skin of acne patients treated with
APS to further elucidate the mechanism of action of this
antiacne compound. Moreover, it is possible that APS ex-
erts its beneficial effects in acne patients via modulating
activation of the mechanistic/mammalian target of ra-
pamycin complex 1 (mTORC1) which is a master regulator
of cellular metabolism. Recently, it was proposed by
Melnik and Schmitz [24] that therapeutic effects of anti-
acne agents are mediated by activation of FoxO1 and in-
hibition of mTORC1. Since proinflammatory NF-jB
activation inhibits tuberous sclerosis complex 1 and
thereby activates mTORC1 a potential link between APS
and mTORC signaling may exist.
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